Valion Bio, LarmorBio Partnership Reaches Initial Feasibility Milestone

Valion Bio's partnership with LarmorBio reached an initial feasibility milestone for BioScan-NMR, less than six months after securing exclusive technology rights. Wholly owned subsidiary Velocity Bioworks completed testing that showed potential to track microbial growth during fermentation. Results support continued development of real-time, noninvasive bioprocess monitoring; further work will assess closed-system and continuous monitoring capabilities. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Valion Bio Inc. published the original content used to generate this news brief on October 15, 2026, and is solely responsible for the information contained therein. (C)